Clinical Trial

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-27; most recent amendment 2026-05-14.
Status change: Not Yet Recruiting → Recruiting 2025-04-01
Trial Details
NCT Number NCT06438445
Lead Sponsor Universidade Federal Fluminense
Conditions Kidney Failure, Chronic, Oxidative Stress, Hemodialysis
Enrollment 30 participants
Start Date 2024-07-30
Primary Completion 2026-12-22 (estimated)
Study Completion 2027-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-18